Aspergillosis
Researchers at the Morehouse School of Medicine have documented a case of invasive sphenoid sinus aspergillosis in a 75-year-old female patient with chronic neutropenia. The patient, who had treated mantle cell lymphoma, developed the rare infection despite not having classical or sustained immunosuppression. The diagnosis was confirmed through imaging and
Immunotherapy
A recent study published in Cancer Letters has made significant advancements in the treatment of rare tumors such as pheochromocytoma and paraganglioma (PCC/PGL) by harnessing the immune system to eliminate tumor cells. The research, conducted by a team of scientists from the Eunice Kennedy Shriver National Institute of Child
Immunotherapy
Research investigators at the Zhengzhou Central Hospital Affiliated to Zhengzhou University have made groundbreaking discoveries on the role of gut microbiota in determining the efficacy of immunotherapy for colon cancer patients. The study, which was recently published in Biochimica et Biophysica Acta, reveals that specific bacterial species and microbial metabolites
Immunotherapy
A new review published in The Kaohsiung Journal of Medical Sciences highlights the potential of nanotechnology in transforming skin cancer treatment. Researchers from Chang Gung University of Science and Technology, led by Ching-Yun Hsu, have summarized the recent advances in nanocarrier-based approaches for skin cancer therapy. The study emphasizes the
Immunotherapy
Researchers at the Shiraz University of Medical Sciences in Iran have made a significant breakthrough in the development of gene therapy for HER2-positive cancers. By creating chimeric antigen receptor (CAR) T cells that co-express IL-15, they have demonstrated enhanced immunotherapy efficacy against these aggressive malignancies. The study, published in the
Immunotherapy
Nutritionist and longevity expert Michiko Tomioka recommends daily consumption of five fruits that promote good health and longevity. Born and raised in Nara, Japan, Tomioka encourages individuals to incorporate these fruits into their diet to boost their immune system and maintain overall well-being. From citrus fruits like oranges, lemons, and
Immunotherapy
Elicio Therapeutics, a clinical-stage biotechnology company, announced plans to present late-breaking data on the immunogenicity and preclinical efficacy of its lead product candidate, ELI-002, at the Society for Immunotherapy of Cancer's (SITC) 40th Anniversary Annual Meeting. The presentation will highlight the promising results from the ongoing Phase 2
Immunotherapy
PredxBio, a leader in AI-driven spatial analytics for precision oncology, will present new clinical and translational results at the Society for Immunotherapy of Cancer (SITC) 2025 Annual Meeting. The company will host a scientific symposium and share findings from four collaborative studies that demonstrate the potential of spatial multi-omic analytics
Cancer research
Scientists from the Institut Pasteur and Inserm have successfully reprogrammed the death of malignant B cells to stimulate an effective anti-tumor immune response, paving the way for a potential therapeutic avenue for certain cancers, including lymphomas and leukemias. By combining three existing drugs, researchers were able to induce necroptosis, a
Immunotherapy
Researchers have made a significant breakthrough in identifying a novel biomarker for predicting prognosis and immunotherapy response in head and neck squamous cell carcinoma (HNSCC). A recent study published in Current Molecular Pharmacology analyzed tumor heterogeneity and its impact on treatment outcomes using single-cell RNA sequencing and spatial transcriptomics. The
Cancer research
The Cancer Immunotherapy Market, which stood at USD 105.7 billion in 2024, is expected to grow to USD 254.6 billion by 2033 at a CAGR of 10.26 percent from 2025 to 2033. This growth is being fueled by the increasing incidence of cancer, research on targeted therapies,
Cancer
Researchers from Chongqing Medical University in China have made a significant discovery in the field of cancer immunotherapy. A new report published in Advanced Healthcare Materials reveals that a novel metal-polyphenol network-coated human serum albumin nanoplatform, dubbed IMT@H, has shown remarkable efficacy in treating HPV-associated malignancies. The nanovaccine combination
